Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages

British Journal of Pharmacology

Volumn 128, Issue 2, 1999, Pages 357-364

  Kang, Young Jin ^a   Koo, Eui Bon ^a   Lee, Young Soo ^a   Yun Choi, Hye Sook ^b   Chang, Ki Churl ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Cytokine; Endotoxin shock; Inducible nitric oxide synthase; Lipopolysaccharide; Murine macrophage; Nitric oxide; Tetrahydroisoquinoline; Vascular smooth muscle

Indexed keywords

ARGININE; GAMMA INTERFERON; INOTROPIC AGENT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; UNCLASSIFIED DRUG; YS 49;

ANIMAL CELL; ARTICLE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; CARDIOTONIC AGENTS; CELLS, CULTURED; CYTOKINES; ENDOTOXINS; ISOQUINOLINES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; MUSCLE, SMOOTH, VASCULAR; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; TETRAHYDROISOQUINOLINES; TRANSCRIPTION, GENETIC;

EID: 0032852097     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702787     Document Type: Article

References (39)

1. AKYEREK, L.M., FELLSTROM, B.C., YAN, Z.Q., HANSSON, G.K., FUNA, K. & LARSSON, E. (1996). Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. Am. J. Pathol., 149, 1981-1990.
2. BISHOP-BAILEY, D., LARKIN, S.W., WARNER, T.D., CHEN, G. & MITCHELL, J.A. (1997). Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br. J. Pharmacol., 121, 125-133.
3. BOUMA, M.G., STAD, R.K., VAN DEN WILDENBERG, F.A. & BUERMAN, W.A. (1994). Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol., 153, 4159 4168.
4. BUSSE, R. & MULSCH, A. (1990). Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275, 87-90.
5. CHANG, K.C., CHUNG, S.Y., CHONG, W.S., SUH, J.S., KIM, S.H., NOH, H.K., SEONG, B.W., KO, H.J. & CHUN, K.W. (1993a). Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats, J. Pharmacol. Exp. Ther., 266, 992-1000.
6. CHANG, K.C., KIM, Y.S. & LEE, S.Y. (1993b). Is the L-arginine/NO pathway involved in photorelaxation in rat aorta? Pharmacol. Commun., 4, 67-75.
7. CHEN, F., SUN, S., KUHN, D.C., LU, Y., GAYDOS, L.J., SHI, X. & DEMERS, L.M. (1997). Tetrandine inhibits NF-κB activation in rat alveolar macrophages. Biochem. Biophys. Res. Commun., 231, 99-102.
8. COOK, J.A., WISE, W.C. & HALUSHKA, P.V. (1980). Elevated thromboxane levels in the rat during endotoxic shock: Protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J. Clin. Invest., 65, 227-230.
9. DEAKIN, A.M., PAYNE, A.N., WHITTLE, B.J. & MONCADA, S. (1995). The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine, 7, 408-416.
10. DENG, W.L. (1990). Antiinflammatory agents from traditional chinese drugs. Drugs of the future. 15, 809-816.
11. GRAY, G.A., FURMAN, B.L. & PARRATT, J.R. (1990). Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites. Circ. Shock, 4, 305-406.
12. HASKO, G., SZABO, C., MERKEL, K., BENCSICS, A., ZINGARELLI, B., KVETAN, V. & VIZI, E.S. (1996). Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol. Lett., 49, 143 147.
13. HOHMANN, H.P., BROCKHAUS, M., BAEUERLE, P.A., REMY, R., KOLBECK, R. & VAN LOON, A.P. (1990). Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. J. Biol. Chem., 265, 22409-22417.
14. IGNATOWSKI, T.A. & SPENGLER, R.N. (1995). Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J. Neuroimmunol., 61, 61-70.
15. JULOU-SCHAEFFER, G., GRAY, G.A., FLEMING, I., SCHOTT, C., PARRATT, J.R. & STOCLEL, J.C. (1990). Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol., 259, H1038-H1043.
16. KANG, Y.J., LEE, G.W., KU, E.B., LEE, H.Y. & CHANG, K.C. (1997). Inhibition by higenamine of lipopolysaccharide-induced iNOS mRNA expression and NO production in rat aorta. Kor. J. Physiol. Pharmacol., 1, 297-302.
17. G-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit. Care. Med., 22, 1835-1840.
18. KONDO, Y., TAKANO, F. & HOJO, H. (1993a). Suppression of lipopolysaccharide-induced fulminant hepatitis and tumor necrosis factor production by bisbenzylisoquinoline alkaloids in bacillus Calmette-Guerin-treated mice. Biochem. Pharmacol., 46, 1861-1863.
19. KONDO, Y., TAKANO, F. & HOJO, H. (1993b). Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages. Biochem. Pharmacol., 46, 1887-1892.
20. LEE, Y.S., KIM, C.H., YEN-CHOI, H.S. & CHANG, K.C. (1994). Cardiovascular effect of a naphtylmethyl substituted tetrahydroisoquinoline, YS 49, in rat and rabbit. Life Sci., 55, PL415-PL429.
21. MCINNES, I.B., LEUNG, B.P., FIELD, M., WEI, X.Q., HUANG, F.-P., STURROCK, R.D., KINNINMONTH, A., WEIDNER, J., MUMFORD, R. & LIEW, F.Y. (1996). Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med., 184, 1519-1524.
22. MCKENNA, T.M. (1990). Prolonged exposure of rat aorta to low levels of endotoxin in Vitro results in impaired contractility. Association with vascular cytokine release. J. Clin. Invest., 86, 160-168.
23. MONASTRA, G. & SECCHI, E.F. (1993). Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharideinduced tumor necrosis factor release. Immunol. Lett., 38, 127-130.
24. MORITOKI, H., HISAYAMA, T., KIDA, K., KONDOH, W., INOUE, S. & TAKAISHI, Y. (1996). Inhibition by triptoquinone-A of LPS- and IL-1 beta-primed induction of NO synthase in rat thoracic aorta. Life Sci., 59, PL49-PL54.
25. NISHIO, M., WATANABE, Y. & HIDAKA, H. (1998). HMN-1180, a small molecular inhibitor of neuronal nitric oxide synthase. J. Pharmacol. Exp. Ther., 287, 1063-1067.
26. PARRATT, J.R. (1989). Alterations in vascular reactivity in sepsis and endotoxemia. In Update in Intensive Care and Emergency Medicine (Vincent, J.L. ed). Springer, Berlin, 299-308.
27. POMERANTZ, K., CASEY, L. FLETCHER, J.R. & RAMWELL, P.W. (1982). Vascular reactivity in endotoxin shock: effect of lidocaine or indomethacin pretreatment. Adv. Shock Res., 7, 191-198.
28. SAKURAI, H., KOHSAKA, H., LIU, M.-F., HIGASHIYAMA, H., JIRATA, Y., KANNO, K., SAITO, I. & MIYASAKI, N. (1995). Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest., 96, 2357 2363.
29. SCHINI, V.B., KATUSIC, Z.S. & VANHOUTTE, P.M. (1990). Neuro-hypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells. J. Pharmacol. Exp. Ther., 255, 994-1000.
30. SCHMIDT, H.H. & WALTER, U. (1994). NO at work. Cell, 78, 919-925.
31. SEKUT, L., CHAMPION, B.R., PAGE, K., MENIUS JR, J.A. & CONNOLLY, K.M. (1995). Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin. Exp. Immunol., 99, 461-466.
32. SEVERN, A., RAPSON, N.T., HUNTER, C.A. & LIEW, F.Y. (1992). Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J. Immunol., 148, 3441-3445.
33. SZABO, C., HASKO, G., ZINGARELLI, B., NEMETH, Z.H., SALZMAN, A.L., KVETAN, V., PASTORES, S.M. & VIZI, E.S. (1997). Isoproterenol regulates tumour necrosis factor, interleukin-10. interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunol., 90, 95-100.
34. THIEMERMANN, C. & VANE, J. (1990). Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol., 182, 591-595.
35. VALLANCE, P., COLLIER, J. & MONCADA, S. (1989). Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovase. Res., 23, 1053-1057.
36. VAN DER POLL, T., COYLE, S.M., BARBOSA, K., BRAXTON, C.C. & LOWRY, S.F. (1996). Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest., 97, 713-719.
37. VINCENT, J.L., ROMAN, A. & KAHN, R.J. (1990). Dobutamine administration in septic shock: addition to a standard protocol. Crit. Care Med., 18, 689-693.
38. WOOD, K.S., BUGA, G.M., BYRNS, R.E. & IGNARRO, L.J. (1990). Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. Biochem. Biophys. Res. Commun., 170, 80-88.
39. XIE, Q. (1997). A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J. Biol. Chem., 272, 14867-14872.